Curatis Holding AG (XSWX:CURN) Other Current Liabilities : CHF5.67 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Other Current Liabilities?

Curatis Holding AG's other current liabilities for the quarter that ended in Jun. 2024 was CHF5.67 Mil.

Curatis Holding AG's quarterly other current liabilities declined from Jun. 2023 (CHF0.48 Mil) to Dec. 2023 (CHF0.26 Mil) but then increased from Dec. 2023 (CHF0.26 Mil) to Jun. 2024 (CHF5.67 Mil).

Curatis Holding AG's annual other current liabilities increased from Dec. 2021 (CHF0.02 Mil) to Dec. 2022 (CHF1.66 Mil) but then declined from Dec. 2022 (CHF1.66 Mil) to Dec. 2023 (CHF0.26 Mil).

Curatis Holding AG Other Current Liabilities Historical Data

The historical data trend for Curatis Holding AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Other Current Liabilities Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

0.02

1.66

0.26

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Current Liabilities	Get a 7-Day Free Trial			1.94	1.66	0.48	0.26	5.67

Curatis Holding AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Curatis Holding AG Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

CURNz:UK 26U:Germany

Address

Weierweg 7, Liestal, CHE, CH-4410

Website

https://www.curatis.com

Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.